Clinical & Medical Directory, Clinical Trials by Symptoms in Belgium

<< Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next >>

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Micafungin Salvage Mono-Therapy in Invasive Aspergillosis
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Isavuconazole for Primary Treatment of Invasive Aspergillosis
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
Isavuconazole in the Treatment of Aspergillosis and Rare Fungi
An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients Aged 12 Years and Older With Cystic Fibrosis Complicated by Allergic Bronchopulmonary Aspergillosis
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients Aged 12 Years and Older With Cystic Fibrosis Complicated by Allergic Bronchopulmonary Aspergillosis
A Study of Staphylococcus Aureus Vaccine (V710) in Patients Scheduled for Cardiothoracic Surgery
Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults.

<< Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next >>